Daxor Corp logo

Daxor Corp

NAS:DXR (USA)  
$ 9.80 +0.06 (+0.62%) 11:57 AM EST
At Loss
P/B:
1.38
Market Cap:
$ 47.10M
Enterprise V:
$ 47.86M
Volume:
5.44K
Avg Vol (2M):
3.01K
Also Trade In:
Volume:
5.44K
At Loss
Avg Vol (2M):
3.01K

Business Description

Description
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Name Current Vs Industry Vs History
Equity-to-Asset 0.98
Debt-to-Equity 0.02
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score 0.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year FCF Growth Rate -8.3
3-Year Book Growth Rate 22.1
Name Current Vs Industry Vs History
5-Day RSI 74.32
9-Day RSI 69.81
14-Day RSI 65.73
6-1 Month Momentum % -9.91
12-1 Month Momentum % -28.17

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6
Shareholder Yield % -6.98

Financials (Next Earnings Date:2024-08-28 Est.)

DXR's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DXR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Daxor Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.281
EPS (TTM) ($) -0.72
Beta -0.2
Volatility % 38.22
14-Day RSI 65.73
14-Day ATR ($) 0.333342
20-Day SMA ($) 9.122075
12-1 Month Momentum % -28.17
52-Week Range ($) 7.11 - 13.128
Shares Outstanding (Mil) 4.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Daxor Corp Filings

Filing Date Document Date Form
No Filing Data

Daxor Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Daxor Corp Frequently Asked Questions

What is Daxor Corp(DXR)'s stock price today?
The current price of DXR is $9.80. The 52 week high of DXR is $13.13 and 52 week low is $7.11.
When is next earnings date of Daxor Corp(DXR)?
The next earnings date of Daxor Corp(DXR) is 2024-08-28 Est..
Does Daxor Corp(DXR) pay dividends? If so, how much?
Daxor Corp(DXR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1